Path to a Bright Future Campaign Partner Interest Form

 
HPV is an extremely common virus affecting everyone - both males and females - that can cause six types of cancer, including cervical, vaginal, anal, penile, and oral/throat cancers. According to the Centers for Disease Control and Prevention (CDC), nearly 80 million Americans – one out of every four people – are infected with the virus. Of those millions, nearly 36,000 will be diagnosed with HPV cancers this year. HPV vaccination is cancer prevention. An established, safe, and effective vaccine that provides long-lasting protection against HPV cancers is available, serving as a vital tool in broad cancer prevention; however, uptake of HPV vaccination in the United States has been slow and lower than the national Healthy People 2030 goal of 80 percent. What’s more, the COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.
 
Collaboration is key to changing this.

Path to a Bright Future Call-to-action


Urgent action is necessary to spread awareness of HPV vaccination and its effectiveness at preventing HPV cancers. The St. Jude Children’s Research Hospital HPV Cancer Prevention Program recommends a coordinated and sustained approach that leverages the latest in public health findings to clearly articulate the dangers of HPV pre-cancers and cancers, in addition to the benefits of vaccination, to parents, the broader public, and healthcare practitioners, in order to: 
 
  • Increase awareness and implementation of evidence-based interventions in community settings;
  • Improve implementation of best practices in clinical settings; and
  • Raise awareness of relevant policies and support vaccination advocacy efforts.
 
Ultimately, we aim to dramatically improve on-time HPV vaccination rates by age 13 in order to reduce the threat of HPV cancers in everyone later in life – locally, regionally and nationally.

Learn more at stjude.org/bright-future. 

Are you interested in partnering with the Path to a Bright Future campaign to prevent HPV cancers, and signing on to the call-to-action above?